NCT00158509View on ClinicalTrials.gov

Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV Shedding

PHASE2CompletedINTERVENTIONAL

Enrollment

215

Participants

Timeline

Start Date

August 31, 2004

Study Completion Date

July 31, 2005

Conditions

Herpes GenitalisHIV Infection

Interventions

DRUG

Valacyclovir

Trial Locations (1)

Unknown

Service d'Hygiene du Centre Muraz, Bobo-Dioulasso

All Listed Sponsors

lead

French National Agency for Research on AIDS and Viral Hepatitis

OTHER_GOV

NCT00158509 - Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV Shedding | Biotech Hunter | Biotech Hunter